- Home
- VHC vs LTRN Comparison
VHC vs LTRN Comparison
Compare VHC & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VHC | LTRN |
|---|---|---|
| Founded | 2005 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Multi-Sector Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 46.0M | 46.8M |
| IPO Year | 2008 | 2020 |
Fundamental Metrics
Financial Performance| Metric | VHC | LTRN |
|---|---|---|
| Price | $13.26 | $2.33 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 13.6K | ★ 82.8K |
| Earning Date | 05-13-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 0.99 | ★ 18.65 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $162,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 3140.00 | N/A |
| 52 Week Low | $9.82 | $1.11 |
| 52 Week High | $29.00 | $4.70 |
Technical Indicators
Market Signals| Indicator | VHC | LTRN |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 28.79 |
| Support Level | N/A | $1.98 |
| Resistance Level | N/A | $2.41 |
| Average True Range (ATR) | 0.00 | 0.20 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 0.00 | 1.49 |
Price Performance
Historical ComparisonAbout VHC VirnetX Holding Corp
VirnetX Holding Corp is engaged in the business of commercializing a portfolio of patents. It is an Internet security software and technology company with patented technology for secure communications. Its software and technology solutions, including its Secure Domain Name Registry and Technology, VirnetX One, War Room, VirnetX Matrix, and GABRIEL Connection Technology, are designed to be device and location-independent, and enable a secure real-time communication environment for all types of enterprise applications, services and critical infrastructures.
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.